ORAL DOSAGE FORM DESIGN AND ITS INFLUENCE ON DISSOLUTION RATES FOR A SERIES OF DRUGS

被引：18
作者：
HOM, FS
MISKEL, JJ
机构：
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1970年 / 59卷 / 06期
关键词：
D O I：
10.1002/jps.2600590622
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：827 / &
相关论文
共 18 条
[1]   EVALUATION OF PHYSICAL AND PHARMACEUTICAL FACTORS INVOLVED IN DRUG RELEASE AND AVAILABILITY FROM CHLORAMPHENICOL CAPSULES [J].
AGUIAR, AJ ;
WHEELER, LM ;
FUSARI, S ;
ZELMER, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (11) :1844-&
[2]   THERAPEUTIC NONEQUIVALENCE OF OXYTETRACYCLINE CAPSULES [J].
BRICE, GW ;
HAMMER, HF .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (07) :1189-&
[3]  
BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346
[4]   IMPORTANCE OF DISSOLUTION RATES IN PRODUCING EFFECTIVE DIAZOXIDE BLOOD LEVELS IN MAN [J].
CALESNICK, B ;
KATCHEN, B ;
BLACK, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (09) :1277-+
[5]   INACTIVE PREDNISONE TABLETS USP XVI [J].
CAMPAGNA, FA ;
NELSONS, E ;
CURETON, G ;
MIRIGIAN, RA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (06) :605-&
[6]   VALIDATION OF METHANOL-SULFURIC ACID COLORIMETRY AS A STABILITY ASSAY METHOD FOR QUINESTROL BY COMPARISON WITH A GAS CHROMATOGRAPHIC PROCEDURE [J].
CHAFETZ, L ;
BOUDJOUK, MG ;
TSILIFON.DC ;
HOM, FS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (06) :1000-&
[7]  
GLAZKO AJ, 1968, CLIN PHARMACOL THER, V9, P472
[8]  
KREUGER EO, 1962, J PHARM SCI, V51, P181
[9]  
LEVY G, 1964, CAN MED ASSOC J, V90, P978
[10]  
LEVY G, 1964, AM J HOSP PHARM, V21, P402
12